Darier disease (DD) is a rare autosomal dominant genodermatosis. This comprehensive review, developed by the Darier Disease International Task Force (DDITF), consolidates current knowledge on the genetic basis, molecular pathophysiology, clinical presentation, diagnosis and management of DD, offering a global perspective that unites shared expertise. The disease arises from pathogenic variants in the ATP2A2 gene, which encodes sarco/endoplasmic reticulum Ca 2+ ‐ATPase isoform 2 (SERCA2), leading to disrupted calcium homeostasis and impaired desmosomal integrity. Clinically, DD is classified based on lesion type (classic vs. non‐classic) and is often accompanied by significant extracutaneous manifestations. Management remains challenging and requires a multifaceted approach, including topical therapies, systemic retinoids and lifestyle modifications. Emerging treatments that target the underlying molecular mechanisms offer promise for improved outcomes. This review aims to provide an updated reference and practical guidance for clinicians involved in the care and study of DD.
Infectious diseases in the form of ‘typhus’ (74.2%) and ‘fevers’ (17.2%) were the commonest conditions accounting for entry to the Wakefield Workhouse Infirmary between 1826 and 1857, as recorded in the admissions book. Skin diseases were noted for 3.2% of admissions, principally scarlet fever (1.5%) and smallpox (0.8%). The mean age for primary dermatological admissions was 20 years (compared with 24 years for patients overall), with a mortality rate of 0.3%. The low number of smallpox cases may be the result of successful vaccination campaigns. The absence of admissions because of scabies (then known as ‘the itch’) might be as a result of exclusion of such patients from entry because of the known extreme infectivity of the condition. Workhouses played an important role in medical care in 19th century Britain but, in this example, skin diseases did not feature highly as causes of admission.
Health conditions have often been associated with stigma and exclusion, leading to social marginalisation and discrimination. Historical references demonstrate how individuals affected by skin diseases were considered ‘defiled’, ostracised and compelled to reside outside the community.1 Although stigma is associated with a number of diseases including HIV/AIDS, tuberculosis and mental health disorders, skin diseases are particularly susceptible to stigma due to their visible nature. Stigma manifests through misunderstandings, entrenched superstitions and fear, leaving those affected vulnerable to judgement, prejudice and social exclusion. Skin diseases can intensify feelings of shame and self-consciousness, limiting a person’s opportunity to fully participate in society.2 Leprosy-related stigma is often described in the literature, but similarly, individuals affected by other skin conditions, like albinism, psoriasis and vitiligo, may also face societal stigma and discrimination impacting mental health, basic human rights and opportunities for marriage and employment.3 4 In the case of albinism, the deep-rooted prejudices, myths and misconceptions can be life-threatening and result in violence, mutilation and even murder.5